Monitoring response to treatment in patients utilizing PET
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 43 (1) , 189-204
- https://doi.org/10.1016/j.rcl.2004.09.006
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Early therapy monitoring with FDG-PET in aggressive non-Hodgkin?s lymphoma and Hodgkin?s lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Positron Emission Tomography in Non–Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose UseJournal of Clinical Oncology, 2003
- Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphomaAnnals of Oncology, 2002
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002
- Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysisThe Lancet, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal CancerNew England Journal of Medicine, 1998
- Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.Radiology, 1995
- Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.Radiology, 1993
- Reporting results of cancer treatmentCancer, 1981